High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study

Kinlay et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69da26158988aeabbe686a3a — DOI: https://doi.org/10.1161/01.cir.0000091404.09558.af

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas.· 1987 · 160 citations
2. Acute-Phase Proteins and Other Systemic Responses to Inflammation· 1999 · 6,681 citations
3. Pathologic detection of early myocardial infarction: a critical review of the evolution and usefulness of modern techniques.· 1999 · 57 citations
4. Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques· 2001 · 997 citations
5. Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>· 2001 · 2,485 citations